Johnson & Johnson hopes to begin late-stage coronavirus vaccine trial ahead of schedule in September – CNBC

Johnson & & Johnson stated it expects to start a late-stage human trial for a possible coronavirus vaccine in late September, ahead of schedule.
The business is in talks with the National Institutes … [+2320 chars]